Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Cost efficiency and formulary considerations for statin therapy.

Killilea T, Funk L.

Am J Manag Care. 2006 Oct;12(11 Suppl):S325-31.

3.
4.

Cost-effectiveness analysis of rosuvastatin versus atorvastatin, simvastatin, and pravastatin from a Canadian health system perspective.

Costa-Scharplatz M, Ramanathan K, Frial T, Beamer B, Gandhi S.

Clin Ther. 2008 Jul;30(7):1345-57.

PMID:
18691996
5.

Effectiveness and cost-effectiveness of rosuvastatin, atorvastatin, and simvastatin among high-risk patients in usual clinical practice.

Ohsfeldt RL, Gandhi SK, Fox KM, Stacy TA, McKenney JM.

Am J Manag Care. 2006 Nov;12(15 Suppl):S412-23.

6.

Statin's cost-effectiveness: a Canadian analysis of commonly prescribed generic and brand name statins.

Tran YB, Frial T, Miller PS.

Can J Clin Pharmacol. 2007 Summer;14(2):e205-14. Epub 2007 Jun 5.

PMID:
17556788
7.

Cost-effectiveness of rosuvastatin compared with other statins from a managed care perspective.

Benner JS, Smith TW, Klingman D, Tierce JC, Mullins CD, Pethick N, O'Donnell JC.

Value Health. 2005 Nov-Dec;8(6):618-28.

8.

A model for assessing the cost-effectiveness of atorvastatin and simvastatin in achieving Canadian low-density lipoprotein cholesterol targets.

Lachaine J, Merikle E, Tarride JE, Montpetit M, Rinfret S.

Clin Ther. 2007 Mar;29(3):519-28.

PMID:
17577472
9.

Effects of direct-to-consumer advertising of hydroxymethylglutaryl coenzyme a reductase inhibitors on attainment of LDL-C goals.

Bradford WD, Kleit AN, Nietert PJ, Ornstein S.

Clin Ther. 2006 Dec;28(12):2105-18; discussion 2104.

PMID:
17296467
10.
13.
14.

Efficacy and cost of HMG-CoA reductase inhibitors in the treatment of patients with primary hyperlipidemia.

Perreault S, Levinton C, Le Lorier J.

Can J Clin Pharmacol. 2000 Autumn;7(3):144-54.

PMID:
11044760
16.

Rising to the challenge of treating high-risk patients.

Guthrie RM.

Am J Manag Care. 2006 Oct;12(11 Suppl):S318-24.

18.

The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.

Roeters van Lennep HW, Liem AH, Dunselman PH, Dallinga-Thie GM, Zwinderman AH, Jukema JW.

Curr Med Res Opin. 2008 Mar;24(3):685-94. doi: 10.1185/030079908X273273. Epub 2008 Jan 25.

PMID:
18226326
20.

The cost effectiveness of statin therapies in Spain in 2010, after the introduction of generics and reference prices.

Plans-RubiĆ³ P.

Am J Cardiovasc Drugs. 2010;10(6):369-82. doi: 10.2165/11539150-000000000-00000.

PMID:
21090830

Supplemental Content

Support Center